RNA, U6 small nuclear 1159, pseudogene (RNU6-1159P)

**RNU6-1159P** is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential non-coding RNA that forms a core part of the spliceosome, which catalyzes the splicing of pre-mRNA in the nucleus of eukaryotic cells[3][2][1]. However, **RNU6-1159P** itself is a processed pseudogene, meaning it is a non-functional genomic copy that does not produce a functional RNA or protein product[5][4]. Pseudogenes like RNU6-1159P arise through retrotransposition or related duplicative events and do not contribute to mRNA splicing or other active biological processes[4]. There is no evidence that RNU6-1159P is a therapeutic target, nor is it associated with known biological functions, drug interactions, or disease roles. Its presence in the genome primarily serves as a molecular relic from the retrotranspositional activity involving U6 snRNA and LINE elements, and it is considered a genomic marker for evolutionary studies of retrotransposition dynamics[4][1]. **Notes on this target:** - RNU6-1159P is *not* a protein-coding gene, receptor, enzyme, transporter, or other canonical pharmacological target. - As a processed pseudogene, RNU6-1159P has no known functional transcript, biological activity, or druggability. - The molecule is sometimes described as “U6 snRNA pseudogene 1159,” and it belongs to the family of U6 snRNA-derived processed pseudogenes. - The entry is *problematic as a drug target* due to lack of function, clinical relevance, and involvement in any pathways amenable to intervention. - Pseudogenes are not classified in therapeutic target families and do not participate in known disease or signaling pathways. **Summary:** RNU6-1159P is a non-functional pseudogene of U6 small nuclear RNA, lacking biological function, disease relevance, and druggability. It should not be considered a true molecular target.

Other names

RNU6-1159PU6 snRNA pseudogene 1159